Workplace and Indoor Aerosols Conference (WIAC2025): Bridging Science and Health

Written by Oliver Dsa, MSc, senior virologist at Airmid Healthgroup, where he leads testing and research on airborne pathogens, indoor air quality, and antiviral technologies in real-world environments.

As the global community continues to confront the challenges posed by indoor air pollution and airborne diseases, the upcoming 6th Workplace and Indoor Aerosols Conference (WIAC2025) emerges as a pivotal event. Scheduled for May 6–8, 2025, at the historic Gaeta Castle in Italy, this conference, themed “Particle Pathways: Exploring the Nexus of Indoor Air Pollution and Airborne Diseases,” aims to bridge critical gaps between public health and environmental science.

Banner for the 6th Workplace and Indoor Aerosols Conference (WIAC2025) held in Gaeta, Italy, from May 6–8, 2025, showcasing the theme'Particle Pathways: Exploring the Nexus of Indoor Air Pollution and Airborne Diseases

Embracing the One Health Paradigm

The conference’s motto, “Sustaining the Indoor Air Paradigm Shift: One Environment, One Health,” encapsulates a holistic approach that recognizes the interconnectedness of human health, environmental factors, and building design. This paradigm shift is crucial in addressing the complex challenges posed by indoor air pollutants and airborne pathogens .By fostering a multidisciplinary dialogue, WIAC2025 aims to bridge the gap between public health and environmental science, leading to innovative solutions for indoor air quality (IAQ) management.

Airmid Healthgroup’s Perspective

At Airmid Healthgroup our mission is to enhance health and wellness by minimizing exposure to harmful indoor air. Our state-of-the-art Aerobiology Test Laboratory and accredited facilities enable us to conduct rigorous testing and research on airborne particulates, allergens, and pathogens. The themes of WIAC2025 resonate deeply with our commitment to advancing IAQ through scientific innovation and practical applications.

Addressing the Critical Intersection

The convergence of indoor air pollution and airborne diseases presents a unique challenge that requires a concerted effort from various disciplines.WIAC2025’s focus on exposure to ambient and viral particles, along with discussions on mitigation measures, aligns with our dedication to evidence-based interventions. Through this conference, we aim to contribute to the development of integrated approaches that safeguard public health while promoting environmental sustainability.

Anticipating Outcomes and Future Collaborations

We look forward to the outcomes of WIAC2025, particularly in fostering collaborations that transcend traditional boundaries. The insights gained from this conference will inform our ongoing efforts to enhance IAQ standards and practices. By bridging the gap between public health and environmental science, we can collectively work towards healthier indoor environments and resilient communities.

Related Tests at Airmid Healthgroup

– Bioaerosol Chamber Testing

– Germicidal UV Testing (ASHRAE 185 Series)

– HVAC Filtration and Air Cleaner Performance Testing (ASHRAE 52.2)

– Antimicrobial Surface Testing (ISO 22196 & ASTM E2149)

Related blogs

– ASHRAE Standard 241: Control of Infectious Aerosols – Understanding its Impact

– An Overview of the ASHRAE 185 Series Standards for Evaluating Air Cleaning Technologies

– The Role of Independent Testing in HVAC Filtration: Ensuring Air Quality Standards

Keywords

WIAC2025, workplace indoor aerosols, indoor air pollution, airborne diseases, particle pathways, One Health paradigm, IAQ management, environmental science, public health, Airmid Healthgroup, indoor air quality, airborne particulates, allergens, pathogens, IAQ standards, scientific innovation, environmental sustainability

Do you want to validate your technology?

Contact the Airmid Healthgroup team today to learn more about the independent testing process and how it can enhance your product’s credibility in the market.

Click Here

author avatar
Oliver Dsa MSc
Oliver Dsa, MSc, is a senior scientist at Airmid Healthgroup and a leading specialist in environmental virology and the transmission dynamics of airborne pathogens. With extensive experience in high-containment laboratory research and virological assay development, Oliver plays a central role in the design and execution of GLP-compliant studies that evaluate the real-world performance of antimicrobial, antiviral, and air purification technologies. At Airmid Healthgroup, Oliver’s work supports global manufacturers, healthcare innovators, and regulatory teams by generating scientifically robust data that withstands scrutiny from FDA, EPA, ISO, and CE marking bodies. He is deeply engaged in testing solutions for infection prevention across healthcare, residential, commercial, and transport environments. Through his contributions to Airmid’s blog, Oliver translates complex virology and bioaerosol science into actionable insights. His writing supports product developers, indoor air quality experts, and public health professionals in navigating the fast-evolving intersection of airborne disease control, ventilation standards (including ASHRAE 241), and surface decontamination strategies. In his blog contributions, Oliver breaks down complex scientific issues—ranging from airborne pathogens to surface decontamination and beyond—into clear, actionable insights for professionals in healthcare, building science, consumer product development, and public health.
Scroll to Top